Salesforce turbocharges $25 billion stock buying spree with debt, cuts cash flow guidance in half

Salesforce reported Q1 fiscal 2027 revenue of $11.1B, up 13% year over year and above guidance, while GAAP EPS rose to $2.42 and non-GAAP EPS to $3.88. The company launched a record $25B accelerated share repurchase, part of a $50B buyback authorization, which cut diluted share count 10% YoY and boosted EPS by 23 cents on non-GAAP and 14 cents on GAAP. However, Salesforce slashed fiscal 2027 free cash flow growth guidance to 4% to 5% from 9% to 10% due to debt-funded buybacks.

Analysis

The key signal is not the buyback itself, but management choosing to monetize the balance sheet to defend the multiple. That usually matters most when a software name is trying to re-anchor expectations after a narrative shock: the repurchase mechanically lifts EPS, but it also tells investors the board sees the stock as undervalued relative to its own long-duration cash generation. In the near term, that can cap downside because the company has effectively become a very large, price-insensitive buyer on dips.

The less obvious effect is competitive. By prefunding repurchases with debt, Salesforce is sacrificing some financial flexibility to support per-share optics now, which increases pressure on peers to show cleaner organic acceleration rather than rely on capital return stories. For NOW, the market read-through is mildly negative: if the category leader has to lean this hard on buybacks to stabilize sentiment, then software multiples remain fragile and investors will be less forgiving of any deceleration in higher-quality names.

The real catalyst over the next 1-2 quarters is whether the promised second-half acceleration shows up in bookings and RPO conversion, not headline revenue. If operating metrics fail to inflect, the market will reclassify this as financial engineering and the EPS benefit from the ASR will be ignored, while leverage and reduced FCF guidance become the focus. Conversely, if Agentforce and core cloud products drive tangible reacceleration, the share repurchase becomes a powerful turbocharger for EPS and free-cash-flow-per-share compounding into fiscal 2028.

Consensus seems to be underestimating how much the market cares about share count in a low-growth software tape: a 10% reduction in diluted shares can materially de-risk the multiple even if absolute growth is only modestly better. But the move is also a warning that management is prioritizing defense over offense, and if AI adoption monetization remains fuzzy, the stock can still underperform despite the buyback. This is a sentiment stabilization trade, not yet a fundamental breakout.

Key Decisions for Investors

• Short-dated bullish CRM structure: buy 1-3 month call spreads on pullbacks, targeting a relief rally if the market starts to price the EPS accretion more than the FCF cut; risk is capped if growth skepticism persists.
• Pair trade: long CRM / short NOW for 1-2 quarters. Thesis is that CRM has a self-funded EPS catalyst via share count reduction, while NOW has less room for narrative support if enterprise software multiple compression resumes; stop if NOW re-accelerates bookings materially.
• Avoid initiating fresh outright longs in CRM after the ASR pop unless you are explicitly trading the buyback support. The easy upside from financial optics is likely in the tape already; better entry is after any post-earnings fade toward support.
• For fundamental portfolios, wait for next quarter's remaining performance obligations and second-half pipeline commentary before adding CRM. The trade improves materially only if bookings growth translates into visible FCF recovery by fiscal Q3-Q4.
• Consider a hedged long in high-quality software baskets versus CRM if you want sector exposure without balance-sheet risk; the debt-funded buyback increases name-specific leverage to any disappointment in AI monetization.